ProShare Advisors’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-46,994
| Closed | -$429K | – | 2097 |
|
|
2025
Q2 | $429K | Buy |
46,994
+32,397
| +222% | +$238K | ﹤0.01% | 1205 |
|
|
2025
Q1 | $116K | Sell |
14,597
-3,684
| -20% | -$27K | ﹤0.01% | 1803 |
|
|
2024
Q4 | $99.3K | Buy |
18,281
+4,350
| +31% | +$26.6K | ﹤0.01% | 2076 |
|
|
2024
Q3 | $101K | Buy |
13,931
+3,135
| +29% | +$28.7K | ﹤0.01% | 1882 |
|
|
2024
Q2 | $117K | Sell |
10,796
-2,917
| -21% | -$37.4K | ﹤0.01% | 1641 |
|
|
2024
Q1 | $257K | Buy |
13,713
+1,130
| +9% | +$26.1K | ﹤0.01% | 1528 |
|
|
2023
Q4 | $273K | Buy |
12,583
+1,801
| +17% | +$35.7K | ﹤0.01% | 1450 |
|
|
2023
Q3 | $222K | Buy |
10,782
+39
| +0.4% | +$1.13K | ﹤0.01% | 1397 |
|
|
2023
Q2 | $505K | Buy |
10,743
+472
| +5% | +$23.5K | ﹤0.01% | 950 |
|
|
2023
Q1 | $431K | Sell |
10,271
-1,353
| -12% | -$58.2K | ﹤0.01% | 977 |
|
|
2022
Q4 | $443K | Buy |
11,624
+882
| +8% | +$33.7K | ﹤0.01% | 1017 |
|
|
2022
Q3 | $420K | Buy |
10,742
+292
| +3% | +$11.3K | ﹤0.01% | 976 |
|
|
2022
Q2 | $338K | Buy |
10,450
+4,339
| +71% | +$145K | ﹤0.01% | 1143 |
|
|
2022
Q1 | $202K | Sell |
6,111
-2,184
| -26% | -$82.1K | ﹤0.01% | 1884 |
|
|
2021
Q4 | $353K | Sell |
8,295
-4,270
| -34% | -$179K | ﹤0.01% | 1688 |
|
|
2021
Q3 | $557K | Buy |
12,565
+2,058
| +20% | +$94.4K | ﹤0.01% | 1144 |
|
|
2021
Q2 | $597K | Buy |
10,507
+2,429
| +30% | +$172K | ﹤0.01% | 1397 |
|
|
2021
Q1 | $605K | Buy |
8,078
+47
| +0.6% | +$3.85K | ﹤0.01% | 1315 |
|
|
2020
Q4 | $695K | Sell |
8,031
-328
| -4% | -$24.2K | ﹤0.01% | 1068 |
|
|
2020
Q3 | $511K | Sell |
8,359
-775
| -8% | -$39.3K | ﹤0.01% | 938 |
|
|
2020
Q2 | $380K | Buy |
9,134
+1,051
| +13% | +$38.1K | ﹤0.01% | 1088 |
|
|
2020
Q1 | $232K | Sell |
8,083
-4,361
| -35% | -$253K | ﹤0.01% | 959 |
|
|
2019
Q4 | $898K | Sell |
12,444
-2,754
| -18% | -$339K | ﹤0.01% | 832 |
|
|
2019
Q3 | $2.13M | Sell |
15,198
-972
| -6% | -$163K | 0.01% | 573 |
|
|
2019
Q2 | $2.96M | Sell |
16,170
-3,151
| -16% | -$538K | 0.02% | 509 |
|
|
2019
Q1 | $3.07M | Buy |
19,321
+2,049
| +12% | +$297K | 0.02% | 514 |
|
|
2018
Q4 | $1.65M | Sell |
17,272
-3,407
| -16% | -$390K | 0.01% | 609 |
|
|
2018
Q3 | $2.92M | Buy |
20,679
+1,131
| +6% | +$175K | 0.02% | 534 |
|
|
2018
Q2 | $3.06M | Sell |
19,548
-7,001
| -26% | -$1.1M | 0.02% | 536 |
|
|
2018
Q1 | $4.28M | Sell |
26,549
-1,487
| -5% | -$252K | 0.03% | 472 |
|
|
2017
Q4 | $4.62M | Buy |
28,036
+4,571
| +19% | +$443K | 0.03% | 440 |
|
|
2017
Q3 | $1.46M | Buy |
23,465
+1,243
| +6% | +$97.6K | 0.01% | 633 |
|
|
2017
Q2 | $1.77M | Sell |
22,222
-1,140
| -5% | -$82.4K | 0.02% | 589 |
|
|
2017
Q1 | $1.66M | Sell |
23,362
-6,034
| -21% | -$353K | 0.02% | 608 |
|
|
2016
Q4 | $1.5M | Buy |
29,396
+6,105
| +26% | +$288K | 0.02% | 634 |
|
|
2016
Q3 | $1.07M | Sell |
23,291
-3,819
| -14% | -$155K | 0.02% | 662 |
|
|
2016
Q2 | $817K | Buy |
27,110
+1,500
| +6% | +$50K | 0.01% | 782 |
|
|
2016
Q1 | $821K | Buy |
25,610
+391
| +2% | +$13.8K | 0.01% | 780 |
|
|
2015
Q4 | $1.47M | Buy |
25,219
+1,919
| +8% | +$95.1K | 0.02% | 604 |
|
|
2015
Q3 | $986K | Sell |
23,300
-1,104
| -5% | -$68K | 0.01% | 673 |
|
|
2015
Q2 | $1.78M | Buy |
24,404
+2,648
| +12% | +$170K | 0.02% | 550 |
|
|
2015
Q1 | $1.09M | Buy |
21,756
+3,444
| +19% | +$148K | 0.01% | 802 |
|
|
2014
Q4 | $670K | Buy |
+18,312
| New | +$683K | 0.01% | 1068 |
|
Other funds holding SAGE
IA
HNB